Dr Reddy's Laboratories Limited: Drug Recall
Recall #D-0923-2023 · 06/21/2023
Class II: Risk
Recall Details
- Recall Number
- D-0923-2023
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Dr Reddy's Laboratories Limited
- Status
- Ongoing
- Date Initiated
- 06/21/2023
- Location
- Ranasthalam Mandal, Srikakulam, N/A, India
- Voluntary/Mandated
- N/A
- Product Quantity
- 17,548 1000-countbottles
Reason for Recall
Failed dissolution specification: Out of specification results observed in 24-month long term stability testing.
Product Description
Tizanidine Tablets USP, 4 mg, 1000-Count bottle, Rx Only, Manufactured by Dr. Reddy's Laboratories Limited Srikakulam - 532 409 India. NDC 55111-180-10
Distribution Pattern
Nationwide in the USA
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.